Comparing Acupuncture With Medication to Reduce Depression, Anxiety and Comorbid Sleep Disorders in China
Recruiting now · Phase 4 · Has a placebo group
Conditions studied: Anxiety Depression, Sleep
In brief
The main objective of this study is to compare medication (usual care; active comparator) with acupuncture (as experimental intervention) to identify the most (cost)effective and environmentally sustainable intervention to reduce depression, anxiety and comorbid sleep disorders in adults (18-65) in China.
Key facts
- Study ID
- NCT07552246
- Run by
- Duke Kunshan University
- People needed
- 180
- Starts
- 2026-04-01
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-07-29
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Chinese nationals 18-65 years old
- At least one of the screening scores below suggestive of depression/anxiety tendencies:
- Depressive state: Depression Self-Rating Scale (SDS) raw score ≥43; standard score ≥53 (27)
- Anxiety state: Anxiety Self-Rating Scale (SAS) raw score ≥40; standard score ≥50 (28) Note: (standard score = raw score X 1.25)
You may not qualify if…
- Patients with severe comorbid physical illnesses that prevent them from completing the full course of treatment;
- Patients with a risk of suicide;
- Patients with a history of head trauma, loss of consciousness, or severe mental disorders;
- Patients with drugs or alcohol abuse;
- Patients who have received physical treatment methods within the past 3 months;
- Patients who have received antidepressant or antipsychotic medication treatment within the past 3 months;
- Patients with severe skin lesions or skin diseases.
Where it is running
- Kunshan Mental Health Center and Kunshan Hospital of Traditional Chinese Medicine — Kunshan, Jiangsu, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.